Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > #$30 in one day.

<< Previous

Bullboard Posts

Next >>

Comment by TeddyTenBagson Mar 08, 2021 9:14pm

211 Views

Post# 32749442

RE:RE:#$30 in one day.

Can you even do basic math? The volume was 4M today, which is double the average daily volume. Sounds like you're down 50% and trying to pump to get your money back. You can't even put coherent sentences together. Probably some paid pumper on the other side of the world living in a mud hut.

maysteeler23 wrote:

Another light volume day big selloff. Feels like the smart money is setting up for Nasdaq Listing.

Watch for a BIG spike in volume to be the tell.